Skip to content

Artelon Metatarsophalangeal (MTP) Spacer

Artelon MTP Spacer - Surgical Treatment of Mild to Moderate Hallux Rigidus

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01028469
Enrollment
15
Registered
2009-12-09
Start date
2009-12-31
Completion date
Unknown
Last updated
2009-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Rigidus, Osteoarthritis

Brief summary

The aim of this prospective, case series is to evaluate the surgical treatment of painful and disabling osteoarthrosis in the MTP-I joint by insertion of an Artelon MTP Spacer.

Interventions

DEVICEArtelon MTP Spacer

Metatarsophalangeal hemi-implant

Sponsors

Artimplant AB
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* The patient experiences pain and limitations of the great toe dorsiflexion at the MTP-I joint. * The patient has a clinically and radiographically verified arthritis in the MTP-I joint indicating the need for surgical treatment. * The patient reads, understands and is able to complete the study questionnaires in Swedish. * The patient has received written and oral information regarding the study and has signed the informed consent form.

Exclusion criteria

* The patient has a pronounced hallux rigidus without mobility in the MTP-I joint (ROM = 0°). * The patient has previously received surgical treatment affecting the anatomy of the MTP-I joint. * The patient has a systemic rheumatic disease, ongoing infection, hallux valgus or is seriously ill.

Design outcomes

Primary

MeasureTime frame
Pain, function and alignment of the treated toe evaluated by the investigator using the American Orthopeadic Foot & Ankle Society (AOFAS) clinical rating system.pre-treatment and 12 months post-op

Countries

Sweden

Contacts

Primary ContactMartin Alund, M.D.
martin.alund@vgregion.se

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026